| Microbiology | Lifetime | 23 | US 15 | 99.54 |
| Infectious Diseases | Lifetime | 105 | US 54 | 99.68 |
| Epidemiology | Lifetime | 808 | US 412 | 98.91 |
| Emergency Medical Services | Lifetime | 362 | US 175 | 96.67 |
| Critical Care and Intensive Care Medicine | Lifetime | 228 | US 103 | 95.45 |
| Applied Microbiology and Biotechnology | Lifetime | 169 | US 59 | 90.41 |
| Emergency Medicine | Lifetime | 854 | US 458 | 89.81 |
| Clinical Biochemistry | Lifetime | 574 | US 248 | 88.64 |
| Modeling and Simulation | Lifetime | 507 | US 104 | 81.81 |
| Molecular Medicine | Lifetime | 628 | US 179 | 66.63 |
| Microbiology | 2021-2025 | 25 | US 11 | 97.47 |
| Infectious Diseases | 2021-2025 | 206 | US 79 | 96.48 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 841 | US 304 | 88.89 |
| Applied Microbiology and Biotechnology | 2021-2025 | 115 | US 40 | 67.00 |
| Modeling and Simulation | 2021-2025 | 351 | US 55 | 64.30 |
| Health | 2021-2025 | 592 | US 242 | 61.16 |
| Medical Device Sterilization and Disinfection | Lifetime | 1 | US 1 | 99.75 |
| Infection Control in Healthcare | Lifetime | 3 | US 2 | 99.78 |
| Infection Control and Ventilation | Lifetime | 6 | US 2 | 99.69 |
| Safe Handling of Antineoplastic Drugs | Lifetime | 3 | US 2 | 99.38 |
| Healthcare and Environmental Waste Management | Lifetime | 10 | US 2 | 98.40 |
| Nosocomial Infections in ICU | Lifetime | 55 | US 21 | 99.32 |
| COVID-19 and healthcare impacts | Lifetime | 213 | US 81 | 96.73 |
| Archaeology and Natural History | Lifetime | 89 | US 73 | 97.80 |
| Vaccine Coverage and Hesitancy | Lifetime | 248 | US 128 | 98.14 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 668 | US 233 | 97.86 |
| Antibiotic Use and Resistance | Lifetime | 210 | US 78 | 98.51 |
| COVID-19 and Mental Health | Lifetime | 427 | US 106 | 96.86 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 305 | US 141 | 97.68 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 366 | US 157 | 98.04 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 480 | US 205 | 97.87 |
| Pneumonia and Respiratory Infections | Lifetime | 709 | US 284 | 97.75 |
| Surgical site infection prevention | Lifetime | 166 | US 96 | 96.96 |
| COVID-19 epidemiological studies | Lifetime | 528 | US 165 | 96.53 |
| Urinary Tract Infections Management | Lifetime | 545 | US 260 | 96.77 |
| Antimicrobial agents and applications | Lifetime | 183 | US 38 | 95.11 |
| Disaster Response and Management | Lifetime | 563 | US 302 | 94.61 |
| Bacterial Infections and Vaccines | Lifetime | 929 | US 342 | 94.30 |
| Burn Injury Management and Outcomes | Lifetime | 380 | US 205 | 93.66 |
| Bartonella species infections research | Lifetime | 154 | US 73 | 90.77 |
| COVID-19 Pandemic Impacts | Lifetime | 927 | US 187 | 86.57 |
| Bacillus and Francisella bacterial research | Lifetime | 979 | US 493 | 88.68 |
| Legionella and Acanthamoeba research | Lifetime | 762 | US 269 | 84.53 |
| Latin American history and culture | Lifetime | 806 | US 485 | 84.33 |
| Intramuscular injections and effects | Lifetime | 418 | US 159 | 77.14 |
| Infection Control in Healthcare | 2021-2025 | 3 | US 1 | 98.94 |
| Medical Device Sterilization and Disinfection | 2021-2025 | 2 | US 1 | 98.96 |
| Infection Control and Ventilation | 2021-2025 | 56 | US 11 | 96.77 |
| COVID-19 and healthcare impacts | 2021-2025 | 390 | US 135 | 93.86 |
| Surgical site infection prevention | 2021-2025 | 74 | US 23 | 92.22 |
| COVID-19 and Mental Health | 2021-2025 | 971 | US 120 | 92.98 |
| Nosocomial Infections in ICU | 2021-2025 | 117 | US 22 | 91.71 |
| Safe Handling of Antineoplastic Drugs | 2021-2025 | 99 | US 19 | 66.76 |
| Legionella and Acanthamoeba research | 2021-2025 | 317 | US 61 | 61.48 |
| Bartonella species infections research | 2021-2025 | 162 | US 39 | 53.29 |
| Healthcare and Environmental Waste Management | 2021-2025 | 706 | US 43 | 56.24 |
